摘要
目的研究国产雷帕霉素药物洗脱支架（Firebird）在冠心病弥漫性长病变中的疗效及安全性。方法 2008年1月1日至2008年12月22日单纯置入Firebird支架的冠心病弥漫性长病变患者72例。随访患者住院期间和出院后主要不良心脏事件（包括心肌梗死、心源性猝死及靶血管再次血运重建术）、心绞痛发作情况等。结果 72例患者术后随访10~24（16.54±6.68）个月,57例心绞痛症状消失（79.17%,57/72）,14例心绞痛复发（19.44%,14/72）,1例猝死（1.39%,1/72）。再狭窄2例（2.78%,2/72）,随访期间发生猝死1例,无急性心肌梗死发生病例。结论国产Firebird药物涂层支架应用于冠心病弥漫性长病变患者中介入治疗是安全有效的。
Objective To study the clinical efficacy and safety of rapamycin eluting stent（Firebird）used in diffuse long lesions in coronary heart disease.Methods The angina frequency and MACE,including myocardial infarction,sudden cardiac death,and revascularization were continuously observed in 72 cases of in-hospital and out patients only implanted Firebird stent from January 1st to December 22nd of 2008.Results 72 cases were followed up for 10~24 months（16.54±6.68）,during which symptoms of 57 cases of angina disappeared（79.17% 57/72）,14 cases of angina recurrence（19.44%,14/72）happened,1 case of sudden death（1.39%,1/72）occurred,and 2 cases of restenosis were observed（2.78%,2/72）.There were no cases of acute myocardial infarction,except 1 case of sudden death in the follow-up period.Conclusion The results suggest that the Firebird drug-coated stent is effective and safe in treating patients with coronary heart disease.
出处
《安徽医学》
2012年第4期449-451,共3页
Anhui Medical Journal
关键词
国产药物支架
弥漫性长病变
冠心病
疗效
Domestic drug-coated stent
Diffuse long lesions
Coronary heart disease
Effect
